Company: MDCXW
Filing Date: 2025-04-25
Form Type: DRS
Source: 0001062993-25-007956
Chunk: 217

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-25
Form: DRS
Chunk 217
---
 the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion. /s/ MNP LLP Chartered Professional Accountants
Licensed Public Accountants We have served as the Company’s auditor since 2014. Mississauga, Canada March 28, 2025 F-3 Medicus Pharma Ltd. Consolidated Financial Statements For the years ended December 31, 2024 and 2023 (expressed in United States dollars, except number of shares) F-4

Medicus Pharma Ltd.
Consolidated Balance Sheets
(expressed in United States dollars)

| Assets                                                                                                                                      
 Current assets:                                                                                                                             |   | December 31, 
         2024 |   |   |        2023 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------------|:--|-------------:|:--|:--|------------:|:--|
| Cash and cash equivalents                                                                                                                   | $ |    4,164,323 |   | $ |   1,719,338 |   |
| Prepaid expenses                                                                                                                            |   |    1,213,984 |   |   |     173,719 |   |
| Total current assets                                                                                                                        |   |    5,378,307 |   |   |   1,893,057 |   |
| Operating lease right-of-use assets                                                                                                         |   |      268,571 |   |   |           - |   |
| Total assets                                                                                                                                |   |    5,646,878 |   |   |   1,893,057 |   |
| Liabilities and Shareholder's equity                                                                                                        |   |              |   |   |             |   |
| Current liabilities:                                                                                                                        |   |              |   |   |             |   |
| Accounts payable                                                                                                                            |   |    1,284,612 |   |   |     210,842 |   |
| Accrued expenses and other current